Stephanie McGrath
Overview
Explore the profile of Stephanie McGrath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coleman A, Creevy K, Anderson R, Reed M, Fajt V, Aicher K, et al.
Geroscience
. 2025 Feb;
PMID: 39951177
Companion dogs are a powerful model for aging research given their morphologic and genetic variability, risk for age-related disease, and habitation of the human environment. In addition, the shorter life...
2.
Talsma B, Elam L, McGrath S, Zhou T, Webb C, Duerr F
Front Vet Sci
. 2024 Oct;
11:1449343.
PMID: 39386246
Introduction: With rapidly growing interest in the use of cannabidiol (CBD) in the management of pain and other conditions, more information is needed on the safety and efficacy of this...
3.
de Linde Henriksen M, McGrath S
J Am Vet Med Assoc
. 2024 Sep;
262(S2):S25-S31.
PMID: 39236742
The 2 most known cannabinoids are Δ9-tetrahydrocannabidiol (THC) and cannabidiol (CBD). Both chemicals are extracted from the cannabis plant but can also be synthetically produced. Δ9-Tetrahydrocannabidiol is extracted from the...
4.
Hargrave S, Bray E, McGrath S, Alexander G, Block T, Chao N, et al.
Geroscience
. 2024 Aug;
47(1):23-43.
PMID: 39106023
Companion dogs are a valuable model for aging research, including studies of cognitive decline and dementia. With advanced age, some dogs spontaneously develop cognitive impairments and neuropathology resembling features of...
5.
Risen S, Boland S, Sharma S, Weisman G, Shirley P, Latham A, et al.
ACS Chem Neurosci
. 2024 Mar;
15(7):1533-1547.
PMID: 38507813
Neuroinflammation plays a crucial role in the development of neurodegenerative protein misfolding disorders. This category of progressive diseases includes, but is not limited to, Alzheimer's disease, Parkinson's disease, and prion...
6.
Jost H, Spitznagel K, Corsato Alvarenga I, Peraza J, Banks K, McGrath S, et al.
Vet Ophthalmol
. 2023 Nov;
27(4):357-366.
PMID: 38032014
Objective: To determine the chronic effects of oral cannabidiol (CBD) use on tear production, intraocular pressure (IOP), and concentration of CBD in tears of healthy dogs. Animals Studied: Eighteen healthy...
7.
Corsato Alvarenga I, Wilson K, McGrath S
J Vet Intern Med
. 2023 Nov;
38(1):326-335.
PMID: 38009749
Background: Cannabidiol (CBD) has therapeutic potential in companion animals. Shorter-term studies have determined that CBD is well tolerated in dogs with mild adverse effects and an increase in alkaline phosphatase...
8.
Rozental A, Weisbeck B, Corsato Alvarenga I, Gustafson D, Kusick B, Rao S, et al.
J Vet Intern Med
. 2023 Oct;
37(6):2291-2300.
PMID: 37889215
Background: Approximately 30% of dogs with idiopathic epilepsy (IE) are drug-resistant. Recent studies have suggested cannabidiol (CBD) may be an effective anticonvulsant in dogs with IE. Objective: To evaluate the...
9.
Spitznagel K, Mikeska R, Jost H, McGrath S, Mehaffy C, de Linde Henriksen M
Vet Ophthalmol
. 2023 Oct;
26(6):565-569.
PMID: 37874256
Purpose: To evaluate the efficacy of the Canine Cytokine SpikeMix™ and MRM-MS for detecting pro-inflammatory cytokines in canine tears from healthy research Beagles. Methods: A complete ophthalmic examination was performed...
10.
Corsato Alvarenga I, Gustafson D, Banks K, Wilson K, McGrath S
Front Vet Sci
. 2023 Oct;
10:1279926.
PMID: 37841465
Introduction: Veterinary hemp products containing cannabidiol (CBD) and negligible psychoactive (THC) have increased popularity since hemp (with <0.3% THC) was removed from schedule 1 substances under the Controlled Substances Act...